Difamilast structure
|
Common Name | Difamilast | ||
---|---|---|---|---|
CAS Number | 937782-05-3 | Molecular Weight | 446.444 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | 3H24F2N2O5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of DifamilastDifamilast (OPA-15406) is a novel potent, selective phosphodiesterase IV (PDE4) inhibitor with preference for PDE4B (IC50=11.2 nM). Dermatitis Phase 2 Clinical |
Name | Difamilast |
---|---|
Synonym | More Synonyms |
Description | Difamilast (OPA-15406) is a novel potent, selective phosphodiesterase IV (PDE4) inhibitor with preference for PDE4B (IC50=11.2 nM). Dermatitis Phase 2 Clinical |
---|---|
References | References 1. Hanifin JM, et al. J Am Acad Dermatol. 2016 Aug;75(2):297-305. View Related Products by Target Phosphodiesterase (PDE) Dermatitis |
Density | 1.2±0.1 g/cm3 |
---|---|
Molecular Formula | 3H24F2N2O5 |
Molecular Weight | 446.444 |
Exact Mass | 446.165314 |
LogP | 4.73 |
Index of Refraction | 1.534 |
Difamilast |
N-({2-[4-(Difluoromethoxy)-3-isopropoxyphenyl]-1,3-oxazol-4-yl}methyl)-2-ethoxybenzamide |
Benzamide, N-[[2-[4-(difluoromethoxy)-3-(1-methylethoxy)phenyl]-4-oxazolyl]methyl]-2-ethoxy- |